Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Three types of the donor(D)-donor'(D')-acceptor(A) triads 1-6 with different D-A combinations, carbazole (Cz, D)-[n.n]
PCP
(D')-1,8-naphthalimide (NI, A) (1-3), 10H-phenothiazine (PTZ, D)-[n.n]
PCP
(D')-NI(A) (4, 5), and 10-methyl-10H-phenothiazine (Me-PTZ, D)-[2.2]PCP-2,1,3-benzothiadiazole (
BTD
, A) 6, were synthesized for the elucidation of their photophysical properties. The absorption spectra and electrochemical properties indicated that the chromophores (D, D', and A) do not interact with each other in the ground state. Cz-(CH2)3-[2.2]
PCP
-(CH2)3-NI 1 and Cz-(CH2)3-[3.3]
PCP
-(CH2)3-NI 2 show an exciplex emission between the
PCP
and NI moieties in cyclohexane and the intensity of the band is much higher in 2 than in 1, whereas Cz-(CH2)2-[2.2]
PCP
-(CH2)2-NI 3 does not show any exciplex emission in cyclohexane. These results indicated that the combination of [3.3]
PCP
and a trimethylene chain is preferable for the exciplex formation. PTZ-(CH2)3-[2.2]
PCP
-(CH2)3-NI 4 shows a broad band at 519 nm in cyclohexane, which is associated with the formation of the exterplex band among the NI, [2.2]
PCP
, and PTZ moieties, while PTZ-(CH2)3-[3.3]
PCP
-(CH2)3-NI 5 does not show the band. Me-PTZ-(CH2)2-[2.2]
PCP
-(CH2)2-
BTD
6 shows a broad fluorescence band due to both the
BTD
and PTZ moieties in cyclohexane. In CH3CN, the fluorescence spectra of 1-6 suggest the presence of a photoinduced charge separation process. The study of the photoinduced charge separation process will be soon reported elsewhere.
...
PMID:Synthesis and electronic and photophysical properties of [2.2]- and [3.3]paracyclophane-based donor-donor'-acceptor triads. 2536 Dec 29